Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
| Revenues: | ||||
| Product Revenue | $ 638,331 | $ 613,198 | $ 2,378,441 | $ 2,307,328 |
| Product Revenue - Related parties | 380 | |||
| License & Service Revenue | 37,500 | 37,500 | ||
| Total Revenues | 675,831 | 613,198 | 2,415,941 | 2,307,708 |
| Cost of Sales: | ||||
| Product Cost of Sales | (323,527) | (236,700) | (872,847) | (713,576) |
| Gross Income | 352,304 | 376,498 | 1,543,094 | 1,594,132 |
| Administrative Expenses | 819,565 | 558,293 | 2,440,023 | 2,298,099 |
| Sales and Marketing Expenses | 342,763 | 408,248 | 1,254,308 | 1,647,003 |
| Sales and Marketing Expenses - Related Party | 34,328 | 117,949 | 128,108 | 117,949 |
| Research and Development Expenses | 290,447 | 247,578 | 929,730 | 932,858 |
| Research and Development Expenses - Related Party | 22,994 | |||
| (Reversal of Allowance for) Bad Debt Expenses- Related parties | (1,299,609) | (1,299,609) | ||
| Amortization of Non-Current Assets | 42,777 | 42,777 | 128,331 | 128,331 |
| (Loss)/Income from Operations | (1,177,576) | 301,262 | (3,360,400) | (2,230,499) |
| Other (Income)/Expenses | ||||
| Foreign Currency Transaction (Gain)/Loss | 3,195 | (3,629) | (6,172) | 1,189 |
| Interest and Dividend Income | (3,127) | (5,264) | (9,296) | (23,981) |
| Other Income | ||||
| Total Other (Income)/Expense | 68 | (8,893) | (15,468) | (22,792) |
| (Loss)/Income Before Income Taxes | (1,177,644) | 310,155 | (3,344,932) | (2,207,707) |
| Income Tax Benefit | ||||
| Net (Loss)/Income Attributable to Common Stockholders | (1,177,644) | 310,155 | (3,344,932) | (2,207,707) |
| Other Comprehensive Income/(Loss) | ||||
| Net Unrealized Gain/(Loss) on Marketable Securities | (1,009) | (2,837) | 3,691 | |
| Total Other Comprehensive Income/(Loss) | (1,009) | (2,837) | 3,691 | |
| Comprehensive (Loss)/Income | $ (1,178,653) | $ 307,318 | $ (3,344,932) | $ (2,204,016) |
| Basic income/(loss) per common share | $ (0.13) | $ 0.06 | $ (0.40) | $ (0.41) |
| Diluted income/(loss) per common share | $ (0.13) | $ 0.06 | $ (0.40) | $ (0.41) |
| Weighted average basic common shares outstanding | 8,892,079 | 5,434,212 | 8,268,851 | 5,428,859 |
| Weighted average diluted common shares outstanding | 8,892,079 | 5,508,545 | 8,268,851 | 5,428,859 |
| X | ||||||||||
- Definition Research and Development Expenses - Related Party. No definition available.
|
| X | ||||||||||
- Definition (Reversal of Allowance for) Bad Debt Expenses - Related parties. No definition available.
|
| X | ||||||||||
- Definition Sales and Marketing Expenses - Related Party. No definition available.
|
| X | ||||||||||
- Definition The expense charged against earnings during the period to allocate the capitalized costs of regulatory assets over the periods expected to benefit from such costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Aggregate revenue during the period from sale of goods in the normal course of business, before deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|